BRPI0408323A - processo para a preparação de compimidos de liberação prolongada - Google Patents
processo para a preparação de compimidos de liberação prolongadaInfo
- Publication number
- BRPI0408323A BRPI0408323A BRPI0408323-7A BRPI0408323A BRPI0408323A BR PI0408323 A BRPI0408323 A BR PI0408323A BR PI0408323 A BRPI0408323 A BR PI0408323A BR PI0408323 A BRPI0408323 A BR PI0408323A
- Authority
- BR
- Brazil
- Prior art keywords
- present
- release
- pharmaceutical composition
- preparation
- sustained release
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 230000002035 prolonged effect Effects 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 4
- 239000008194 pharmaceutical composition Substances 0.000 abstract 3
- 229920002678 cellulose Polymers 0.000 abstract 2
- 239000001913 cellulose Substances 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 2
- 238000013268 sustained release Methods 0.000 abstract 2
- 239000012730 sustained-release form Substances 0.000 abstract 2
- 229920002774 Maltodextrin Polymers 0.000 abstract 1
- 239000005913 Maltodextrin Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229940035034 maltodextrin Drugs 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000006187 pill Substances 0.000 abstract 1
- 239000007939 sustained release tablet Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
"PROCESSO PARA A PREPARAçãO DE COMPRIMIDOS DE LIBERAçãO PROLONGADA". A presente invenção se refere a um novo processo para a preparação de comprimidos de liberação prolongada contendo compostos medicinais e aos produtos preparados por esse processo. A presente invenção se refere a um processo de preparação de uma composição farmacêutica de liberação prolongada com um perfil predeterminado de liberação de medicamento, mas que se desvie dele pela adição de uma quantidade eficaz para a formação de comprimidos de uma celulose insolúvel ou parcialmente insolúvel em água à composição farmacêutica, composta por um medicamento em uma quantidade terapeuticamente eficaz, um veículo de liberação prolongada, presente em quantidades eficaz para retardar a liberação do medicamento da composição farmacêutica, e a celulose, esta última estando presente em um sistema aquoso, o aperfeiçoamento compreendendo a adição à composição de uma quantidade eficaz de maltodextrina para retardar o aumento da taxa de liberação do medicamento pela adição da celulose a ele.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US45480303P | 2003-03-14 | 2003-03-14 | |
PCT/US2004/007826 WO2004082615A2 (en) | 2003-03-14 | 2004-03-15 | A process for preparing sustained release tablets |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0408323A true BRPI0408323A (pt) | 2006-03-07 |
Family
ID=33029912
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0408323-7A BRPI0408323A (pt) | 2003-03-14 | 2004-03-15 | processo para a preparação de compimidos de liberação prolongada |
Country Status (9)
Country | Link |
---|---|
US (2) | US20040224017A1 (pt) |
EP (1) | EP1603540A2 (pt) |
JP (1) | JP2006520390A (pt) |
AU (1) | AU2004222339A1 (pt) |
BR (1) | BRPI0408323A (pt) |
CA (1) | CA2518734A1 (pt) |
MX (1) | MXPA05009886A (pt) |
NZ (1) | NZ542303A (pt) |
WO (1) | WO2004082615A2 (pt) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10179130B2 (en) | 1999-10-29 | 2019-01-15 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
ATE526950T1 (de) | 1999-10-29 | 2011-10-15 | Euro Celtique Sa | Hydrocodon-formulierungen mit gesteuerter freisetzung |
WO2002036099A1 (en) | 2000-10-30 | 2002-05-10 | Euro-Celtique S.A. | Controlled release hydrocodone formulations |
CA2359812C (en) * | 2000-11-20 | 2004-02-10 | The Procter & Gamble Company | Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures |
CA2518734A1 (en) * | 2003-03-14 | 2004-09-30 | Nirmal Mulye | A process for preparing sustained release tablets |
AU2004289252C1 (en) | 2003-11-08 | 2013-06-20 | Prothera Biologics, Inc. | Preparation and composition of Inter-alpha inhibitor proteins from human plasma for therapeutic use |
US20070161711A1 (en) * | 2003-12-23 | 2007-07-12 | Temrel Limited | Process for producing pellets for pharmaceutical compositions |
MXPA06010047A (es) * | 2004-03-10 | 2007-03-07 | Taisho Pharma Co Ltd | Preparacion farmaceutica solida que contiene farmaco escasamente soluble en agua. |
BRPI0610257A2 (pt) * | 2005-04-25 | 2010-06-08 | Teva Pharma | formulações de liberação prolongada |
US20080058408A1 (en) | 2006-05-19 | 2008-03-06 | Rogowski Roberta L | Low-dose doxepin for treatment of sleep disorders in elderly patients |
US20100179215A1 (en) | 2006-05-19 | 2010-07-15 | Somaxon Pharmaceuticals, Inc. | Doxepin isomers and isomeric mixtures and methods of using the same to treat sleep disorders |
WO2007136741A2 (en) * | 2006-05-19 | 2007-11-29 | Somaxon Pharmaceuticals, Inc. | N-desmethyl-doxepin and methods of using the same to treat sleep disorders |
CA2687118A1 (en) | 2006-05-19 | 2007-12-13 | Somaxon Pharmaceuticals, Inc. | Methods of using low-dose doxepin for the improvement of sleep |
US20100179214A1 (en) | 2006-05-19 | 2010-07-15 | Somaxon Pharmaceuticals, Inc. | Doxepin trans isomers and isomeric mixtures and methods of using the same to treat sleep disorders |
US20080069891A1 (en) * | 2006-09-15 | 2008-03-20 | Cima Labs, Inc. | Abuse resistant drug formulation |
CA2693992C (en) | 2006-07-20 | 2017-01-31 | Somaxon Pharmaceuticals, Inc. | Methods of improving the pharmacokinetics of doxepin |
US8445018B2 (en) * | 2006-09-15 | 2013-05-21 | Cima Labs Inc. | Abuse resistant drug formulation |
WO2008052139A2 (en) | 2006-10-25 | 2008-05-02 | Somaxon Pharmaceuticals, Inc. | Ultra low dose doxepin and methods of using the same to treat sleep disorders |
US20110077200A1 (en) | 2006-12-06 | 2011-03-31 | Somaxon Pharmaceuticals, Inc. | Combination therapy using low-dose doxepin for the improvement of sleep |
CA2673111A1 (en) * | 2006-12-07 | 2008-06-19 | Schering Corporation | Ph sensitive matrix formulation |
WO2008128115A2 (en) | 2007-04-13 | 2008-10-23 | Somaxon Pharmaceuticals, Inc. | Low-dose doxepin formulations |
US20090036414A1 (en) * | 2007-08-02 | 2009-02-05 | Mutual Pharmaceutical Company, Inc. | Mesalamine Formulations |
EP2200613B1 (en) | 2007-09-21 | 2018-09-05 | The Johns Hopkins University | Phenazine derivatives and uses thereof |
WO2009042778A1 (en) * | 2007-09-25 | 2009-04-02 | Nirmal Mulye | Controlled release pharmaceutical compositions |
KR101569604B1 (ko) * | 2007-12-28 | 2015-11-16 | 임팩스 라보라토리즈, 인코포레이티드 | 레보도파 방출 제어형 제제 및 이의 용도 |
PT2291654T (pt) | 2008-05-28 | 2018-06-15 | Prothera Biologics Inc | Preparação e composição de proteínas inibidoras de interalfa do sangue |
MX2012012991A (es) | 2010-05-11 | 2012-11-30 | Cima Labs Inc | Formas de dosificacion oral de liberacion prolongada resistentes al alcohol y que contienen metoprolol. |
CN104010630A (zh) * | 2011-12-09 | 2014-08-27 | 普渡制药公司 | 包含聚(ε-己内酯)和聚氧乙烯的药物剂型 |
NZ627980A (en) * | 2012-02-07 | 2016-12-23 | Biogen Ma Inc | Pharmaceutical compositions containing dimethyl fumarate |
WO2014039987A2 (en) | 2012-09-09 | 2014-03-13 | Prothera Biologics, Inc. | Treatment of disease using inter-alpha inhibitor proteins |
EP3272837B1 (en) * | 2016-07-21 | 2021-01-27 | Bharat Petroleum Corporation Limited | Fuel composition containing lubricity improver and method thereof |
CN111836618A (zh) * | 2018-02-08 | 2020-10-27 | 景凱生物科技股份有限公司 | 类阿片受体拮抗剂的固体剂型用的医药剂型 |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4792452A (en) * | 1987-07-28 | 1988-12-20 | E. R. Squibb & Sons, Inc. | Controlled release formulation |
US5057321A (en) * | 1990-06-13 | 1991-10-15 | Alza Corporation | Dosage form comprising drug and maltodextrin |
US5773031A (en) * | 1996-02-27 | 1998-06-30 | L. Perrigo Company | Acetaminophen sustained-release formulation |
PT998271E (pt) * | 1997-06-06 | 2005-10-31 | Depomed Inc | Formas de dosagem oral de farmacos com retencao gastrica para a libertacao controlada de farmacos altamente soluveis |
PT991409E (pt) * | 1997-08-01 | 2002-06-28 | Elan Corp Plc | Composicoes farmaceuticas de libertacao controlada contendo tiagabina |
AU8699298A (en) * | 1997-08-11 | 1999-03-01 | Alza Corporation | Prolonged release active agent dosage form adapted for gastric retention |
US6056977A (en) * | 1997-10-15 | 2000-05-02 | Edward Mendell Co., Inc. | Once-a-day controlled release sulfonylurea formulation |
FR2772615B1 (fr) * | 1997-12-23 | 2002-06-14 | Lipha | Comprime multicouche pour la liberation instantanee puis prolongee de substances actives |
FI980901A (fi) * | 1998-04-23 | 1999-10-24 | Orion Yhtymae Oyj | Levosimendaania säädellysti vapauttavia oraalisia koostumuksia |
US6368625B1 (en) * | 1998-08-12 | 2002-04-09 | Cima Labs Inc. | Orally disintegrable tablet forming a viscous slurry |
US6117451A (en) * | 1998-08-25 | 2000-09-12 | Pharmalogix, Inc. | Direct compression metformin hydrochloride tablets |
ATE424810T1 (de) * | 1998-12-11 | 2009-03-15 | Nostrum Pharmaceuticals Inc | Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung |
ES2212667T3 (es) * | 1998-12-18 | 2004-07-16 | Abbott Laboratories | Formulacion de liberacion controlada con divalproex sodico. |
US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
CO5210862A1 (es) * | 1999-09-15 | 2002-10-30 | Alza Corp | Formas de dosificacion y metodos para proporcionar efectiva terapia de reboxetina con dosificacion de una vez al dia |
MXPA02004413A (es) * | 1999-11-02 | 2002-09-02 | Depomed Inc | Induccion farmacologica del modo de alimentacion, para la administracion aumentada de drogas al estomago. |
CA2393344C (en) * | 1999-12-03 | 2009-09-01 | Polichem S.A. | Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof |
DE10014588A1 (de) * | 2000-03-27 | 2001-10-04 | Basf Ag | Wirkstoffhaltige Schwimmformen enthaltend Polyvinylacetat und Polyvinylpyrrolidon, deren Verwendung und Herstellung |
US6399101B1 (en) * | 2000-03-30 | 2002-06-04 | Mova Pharmaceutical Corp. | Stable thyroid hormone preparations and method of making same |
AR030557A1 (es) * | 2000-04-14 | 2003-08-27 | Jagotec Ag | Una tableta en multicapa de liberacion controlada y metodo de tratamiento |
AU2001100195B4 (en) * | 2001-01-05 | 2001-12-20 | H Lundbeck As | Pharmaceutical composition containing citalopram. |
US6544552B2 (en) * | 2001-01-11 | 2003-04-08 | Particle And Coating Technologies, Inc. | Method of producing porous tablets with improved dissolution properties |
EP1226818A1 (en) * | 2001-01-26 | 2002-07-31 | Pfizer Products Inc. | Pharmaceutical dosage forms with enhanced cohesive and compressibility properties |
US20020176841A1 (en) * | 2001-03-19 | 2002-11-28 | Praecis Pharmaceuticals Inc. | Pharmaceutical formulations for sustained release |
JP2004530676A (ja) * | 2001-04-18 | 2004-10-07 | ノストラム・ファーマスーティカルズ・インコーポレイテッド | 持続放出性薬学的組成物のための新規コーティング |
GB0117619D0 (en) * | 2001-07-19 | 2001-09-12 | Phoqus Ltd | Pharmaceutical dosage form |
CA2518734A1 (en) * | 2003-03-14 | 2004-09-30 | Nirmal Mulye | A process for preparing sustained release tablets |
-
2004
- 2004-03-15 CA CA002518734A patent/CA2518734A1/en not_active Abandoned
- 2004-03-15 NZ NZ542303A patent/NZ542303A/en unknown
- 2004-03-15 US US10/800,984 patent/US20040224017A1/en not_active Abandoned
- 2004-03-15 JP JP2006507189A patent/JP2006520390A/ja active Pending
- 2004-03-15 AU AU2004222339A patent/AU2004222339A1/en not_active Abandoned
- 2004-03-15 MX MXPA05009886A patent/MXPA05009886A/es unknown
- 2004-03-15 EP EP04720805A patent/EP1603540A2/en not_active Withdrawn
- 2004-03-15 BR BRPI0408323-7A patent/BRPI0408323A/pt not_active IP Right Cessation
- 2004-03-15 WO PCT/US2004/007826 patent/WO2004082615A2/en active Application Filing
-
2010
- 2010-08-20 US US12/860,032 patent/US20110071137A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2004082615A2 (en) | 2004-09-30 |
US20110071137A1 (en) | 2011-03-24 |
JP2006520390A (ja) | 2006-09-07 |
EP1603540A2 (en) | 2005-12-14 |
AU2004222339A1 (en) | 2004-09-30 |
NZ542303A (en) | 2008-12-24 |
MXPA05009886A (es) | 2006-05-04 |
CA2518734A1 (en) | 2004-09-30 |
WO2004082615A3 (en) | 2004-11-25 |
US20040224017A1 (en) | 2004-11-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0408323A (pt) | processo para a preparação de compimidos de liberação prolongada | |
BRPI0607549A2 (pt) | sistemas de distribuição farmacêutica para fármacos hidrófobos e composições compreendendo os mesmos | |
BR9908488A (pt) | Composição farmacêutica de topiramato | |
BR9913696A (pt) | Sistema de liberação de drogas, administrado oralmente, proporcionando controle temporal e espacial | |
BR0212008A (pt) | Uso de um composto ou de um sal, solvato ou pró-medicamento deste, composição farmacêutica, composto ou um sal, solvato ou pró-medicamento deste, e, processo para a preparação deste | |
BR0211601A (pt) | Polimorfo estável de flibanserina, processo técnico para a preparação do mesmo e o uso do mesmo para a preparação de medicamentos | |
TW200716208A (en) | Modified and immediate release memantine bead formulation | |
TW200630123A (en) | Oral medicinal product with modified release of at least one active principle in multimicrocapsular form | |
BR0015188A (pt) | Composições farmacêuticas | |
BR0112589A (pt) | Derivados de heteroarila e sua aplicação como medicamento | |
CY1107828T1 (el) | Θεραπευτικα βιοπροσκολλητικα συστηματα παρατεταμενης αποδεσμευσης | |
BR9506029A (pt) | Forma farmaêutica oral de múltipla dosagem unitária em tablete processo para a preparação da mesma para a inibição da secreção de ácido gástrico em mamiferos e no homem para o tratamento de doenças inflamatórias gastrointestinais em maniferos e no homem e embalgem de ampola de pressão transversal | |
HUP0303325A2 (hu) | Gyógyászati sók és ezeket tartalmazó gyógyászati készítmények | |
BRPI0717673B8 (pt) | composição de oligogalacturonanas, biomaterial e têxtil | |
BRPI0620229B8 (pt) | formulações farmaceuticas e processos de produção da ditas formulações | |
BR9810197A (pt) | Produto, compostos, processo de preparação destes, composição farmacêutica, e, utilização de um produto | |
NO20082047L (no) | Sakte frigivende sammensetning, fremgangsmate for fremstilling derav og anvendelse av samme | |
BRPI0411413A (pt) | composições para revestimento entérico de um produto natural e de microcápsulas com revestimento entérico contendo lectina | |
BRPI0518789A2 (pt) | formulaÇço farmacÊutica, processo para preparar uma formulaÇço farmacÊutica, produto, e, cÁpsula ou tablete | |
BR0211198A (pt) | Composições farmacêuticas e seu uso | |
BR0312728A (pt) | Formulação em tablete dispersìvel e processo para sua preparação | |
BR0008713A (pt) | Processos para preparar formulações ecomposições farmacêuticas orais com ecb | |
BR0212155A (pt) | Composição farmacêutica | |
BRPI0518790A2 (pt) | formulaÇço farmacÊutica, processo para preparar uma formulaÇço farmacÊutica, produto, e, cÁpsula ou tablete | |
BR0212931A (pt) | Composição farmacêutica de liberação prolongada contendo metformina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A ANUI DADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2129 DE 25/10/2011. |